Brief: United Therapeutics Commences Litigation With US Food And Drug Administration
21/02/2024 11:04
Feb 21 (Reuters) - United Therapeutics Corp UTHR.O :
* UNITED THERAPEUTICS CORP - COMMENCEMENT OF LITIGATION WITH
UNITED STATES FOOD AND DRUG ADMINISTRATION (FDA)
* UNITED THERAPEUTICS- CO ALLEGES FDA "MISTAKENLY" LET
LIQUIDIA
CORP SKIRT FDA RULES ON HOW PENDING DRUG APPROVAL APPLICATIONS
ARE HANDLED BY AGENCY
Source text for Eikon: ID:nBw8crzgga
Further company coverage: UTHR.O
((Reuters.Briefs@thomsonreuters.com))
Recent news on United Therapeutics
See all newsBrief: United Therapeutics Corporation Announces Additional $2 Billion Share Repurchase Authorization
Brief: United Therapeutics Announces FDA Clearance To Proceed With Summit Clinical Trial For Treprostinil Smi In Ph-Copd
Liquidia surges as United Therapeutics settlement removes key litigation risk (updated)
Brief: United Therapeutics Enters Settlement Agreement With Liquidia To Resolve Litigation - SEC Filing
Liquidia surges after $381 million settlement with United Therapeutics for lung disease drug